Welcome to our dedicated page for Radnet SEC filings (Ticker: RDNT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
RadNet, Inc. filings document material-event disclosures for operating results, financial condition, governance, capital structure, and corporate actions tied to its diagnostic imaging and digital health businesses. Recent Form 8-K reports furnish quarterly results press releases and exhibits, including segment information for Imaging Centers and Digital Health.
The company’s proxy materials address board matters, executive compensation, and shareholder voting items. Other filings include leadership and compensatory-arrangement disclosures, prospectus supplements under automatic shelf registration statements for common stock resale registrations, and acquisition-related share issuance matters associated with RadNet’s health informatics expansion.
RadNet, Inc. executive Cornelis Wesdorp, Pres & CEO, Digital Health, reported an open-market sale of 4,750 shares of Common Stock at $58.11 per share. After this transaction, he directly owns 69,075 shares, indicating he retains a substantial equity position in the company.
RadNet, Inc. President and CEO Howard G. Berger reported an insider transaction involving a small stock gift. On this Form 4, his spouse made a bona fide gift of 90 shares of RadNet common stock to her relatives' trusts, with no sale proceeds and a reported price of zero.
Following the reported transactions, Berger holds 498,405 shares of common stock directly, and his spouse holds 19,910 shares indirectly attributed to him. The filing reflects a routine, non-market transfer rather than an open‑market purchase or sale.
Morgan Stanley Smith Barney LLC submitted a Form 144 notice reporting securities related to Common stock for RDNT. The filing lists 4,750, a monetary figure of $269,372.50, and the number 78,634,236 with 06/16/2026 and NASDAQ as exchange details.
The filing also itemizes two compensation-related entries dated 10/01/2024 for 3,495 and 10/01/2025 for 1,255. The "Securities Sold During The Past 3 Months" row is present but contains no amounts in the excerpt.
RadNet, Inc. executive Stephen M. Forthuber, President and CEO of Eastern Operations, reported open-market sales of company common stock. He sold a total of 44,067 shares in two transactions at weighted average prices of about $58.61 and $57.79 per share, with individual trades occurring within the disclosed price ranges. Following these sales, he continues to directly hold over 500,000 RadNet shares, indicating that the transactions represent a partial reduction rather than an exit from his position.
Morgan Stanley Smith Barney LLC notified a proposed sale of 44,067 shares of RDNT common stock under Rule 144. The notice lists three vesting cohorts: 18,935 shares (03/10/2025), 12,566 shares (05/01/2017), and 12,566 shares (01/06/2017).
RadNet, Inc. entered into Incremental Amendment No. 3 to its first lien credit and guaranty agreement, securing a new $250.0 million 2026 Incremental Term Loan that is added to its existing term loan facility. The combined Term Loan now matures on April 18, 2031 and carries an interest rate reduced by 0.25% to either Term SOFR plus 2.00% or the alternate base rate plus 1.00%.
Quarterly principal payments on the Term Loan will increase to about $3.1 million, up from roughly $2.4 million. The proceeds are expected to fund future acquisitions, organic expansion, health system partnerships and general corporate purposes. RadNet also reduced the interest rate on its undrawn $282 million revolving credit facility by 0.25%, and highlighted that the new funds supplement a $455 million cash balance as of March 31, 2026 to support its growth strategy.
RadNet, Inc. entered into Incremental Amendment No. 3 to its first lien credit and guaranty agreement, securing a new $250.0 million 2026 Incremental Term Loan that is added to its existing term loan facility. The combined Term Loan now matures on April 18, 2031 and carries an interest rate reduced by 0.25% to either Term SOFR plus 2.00% or the alternate base rate plus 1.00%.
Quarterly principal payments on the Term Loan will increase to about $3.1 million, up from roughly $2.4 million. The proceeds are expected to fund future acquisitions, organic expansion, health system partnerships and general corporate purposes. RadNet also reduced the interest rate on its undrawn $282 million revolving credit facility by 0.25%, and highlighted that the new funds supplement a $455 million cash balance as of March 31, 2026 to support its growth strategy.
SWARTZ DAVID L reported acquisition or exercise transactions in this Form 4 filing.
RadNet, Inc. director David L. Swartz reported an equity compensation grant of 2,946 shares of common stock, recorded at a price of $0.00 per share, meaning no cash outlay was required. Following this award, he holds 179,712 common shares directly and 37,019 shares indirectly through his spouse. This filing reflects a routine stock grant rather than an open-market purchase or sale.
RadNet, Inc. director Gregory E. Spurlock reported receiving a grant of 2,946 shares of Common Stock on June 2, 2026. The shares were acquired at a stated price of $0.00 per share, indicating they were awarded rather than purchased on the open market.
Following this transaction, Spurlock directly holds a total of 8,236 shares of RadNet common stock. The filing reflects a routine equity award that increases his direct ownership stake but does not involve any reported share sales or option exercises.
Jacobs Laura Pastre reported acquisition or exercise transactions in this Form 4 filing.
RadNet, Inc. director Laura Pastre Jacobs received a grant of 2,946 shares of Common Stock on 2026-06-02 at no cost per share. Following this compensation-related award, she directly owns 29,953 shares of RadNet Common Stock.